Virtus LifeSci Performance

BBC -- USA Etf  

USD 26.52  0.56  2.07%

The entity has beta of 0.1879 which indicates as returns on market increase, Virtus LifeSci returns are expected to increase less than the market. However during bear market, the loss on holding Virtus LifeSci will be expected to be smaller as well.. Even though it is essential to pay attention to Virtus LifeSci Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-one different technical indicators which can help you to evaluate its performance.
Horizon     30 Days    Login   to change

Virtus LifeSci Biotech Relative Risk vs. Return Landscape

If you would invest  2,918  in Virtus LifeSci Biotech Clinical Trls ETF on November 13, 2018 and sell it today you would lose (210.00)  from holding Virtus LifeSci Biotech Clinical Trls ETF or give up 7.2% of portfolio value over 30 days. Virtus LifeSci Biotech Clinical Trls ETF is generating negative expected returns assuming volatility of 3.264% on return distribution over 30 days investment horizon. In other words, 29% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, Virtus LifeSci Biotech Clinical Trls ETF is expected to under-perform the market. In addition to that, the company is 2.49 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.06 per unit of volatility.

Virtus LifeSci Market Risk Analysis

Sharpe Ratio = -0.0358
Good Returns
Average Returns
Small Returns
Negative ReturnsBBC

Virtus LifeSci Relative Performance Indicators

Estimated Market Risk
  actual daily
 29 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Virtus LifeSci is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.

Virtus LifeSci Performance Rating

Virtus LifeSci Biotech Clinical Trls ETF Risk Adjusted Performance Analysis


Risk-Adjusted Performance

Over the last 30 days Virtus LifeSci Biotech Clinical Trls ETF has generated negative risk-adjusted returns adding no value to investors with long positions.

Virtus LifeSci Alerts

Equity Alerts and Improvement Suggestions

Virtus LifeSci generates negative expected return over the last 30 days
Virtus LifeSci has high historical volatility and very poor performance
Latest headline from Copper ETFs Rust as Trade War Fears Reignite - ETF Trends
The fund generated three year return of -4.0%
Virtus LifeSci Biotech Clinical Trls ETF holds 96.91% of its assets under management (AUM) in equities

Virtus LifeSci Performance Indicators

Virtus LifeSci Biotech Basic Price Performance Measures

Fifty Two Week Low25.1200
Fifty Two Week High36.2500

Virtus LifeSci Dividends

Virtus LifeSci Biotech Dividends Analysis

Check Virtus LifeSci Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Check also Trending Equities. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.